TXG logo

10x Genomics (TXG) Company Overview

Profile

Full Name:

10x Genomics, Inc.

Sector:

Healthcare

Country:

United States

IPO:

September 12, 2019

Indexes:

Not included

Description:

10x Genomics, Inc. is an American biotechnology company that develops and manufactures gene sequencing technology used in scientific research. Registered in 2012 in the state of Delaware. The company offers tools, consumables, and software for analyzing biological systems at a resolution and scale that allows for analysis at the cellular level. Integrated solutions are used by biotechnology companies specializing in fundamental research in the fields of biology and medicine, including oncology, immunology, and neurobiology.

Events Calendar

Earnings

Next earnings date:

Apr 30, 2025

Recent quarterly earnings:

Feb 12, 2025

Recent annual earnings:

Feb 12, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 17, 2006

Analyst ratings

Recent major analysts updates

Feb 14, 25 Morgan Stanley
Overweight
Feb 14, 25 Barclays
Overweight
Feb 13, 25 UBS
Neutral
Feb 13, 25 Stifel
Buy
Feb 13, 25 Leerink Partners
Market Perform
Feb 13, 25 JP Morgan
Neutral
Feb 13, 25 Citigroup
Buy
Feb 13, 25 Canaccord Genuity
Buy
Feb 10, 25 Barclays
Overweight
Jan 13, 25 Morgan Stanley
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for 10x Genomics?
  • Does 10x Genomics pay dividends?
  • What sector is 10x Genomics in?
  • What industry is 10x Genomics in?
  • What country is 10x Genomics based in?
  • When did 10x Genomics go public?
  • Is 10x Genomics in the S&P 500?
  • Is 10x Genomics in the NASDAQ 100?
  • Is 10x Genomics in the Dow Jones?
  • When was 10x Genomics's last earnings report?
  • When does 10x Genomics report earnings?
  • Should I buy 10x Genomics stock now?

What is the ticker symbol for 10x Genomics?

The ticker symbol for 10x Genomics is NASDAQ:TXG

Does 10x Genomics pay dividends?

No, 10x Genomics does not pay dividends

What sector is 10x Genomics in?

10x Genomics is in the Healthcare sector

What industry is 10x Genomics in?

10x Genomics is in the Health Information Services industry

What country is 10x Genomics based in?

10x Genomics is headquartered in United States

When did 10x Genomics go public?

10x Genomics's initial public offering (IPO) was on September 12, 2019

Is 10x Genomics in the S&P 500?

No, 10x Genomics is not included in the S&P 500 index

Is 10x Genomics in the NASDAQ 100?

No, 10x Genomics is not included in the NASDAQ 100 index

Is 10x Genomics in the Dow Jones?

No, 10x Genomics is not included in the Dow Jones index

When was 10x Genomics's last earnings report?

10x Genomics's most recent earnings report was on Feb 12, 2025

When does 10x Genomics report earnings?

The next expected earnings date for 10x Genomics is Apr 30, 2025

Should I buy 10x Genomics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions